Timothy Wright - 01 Oct 2025 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Director
Signature
/s/Christine Klaskin as Attorney-in-Fact for Timothy R. Wright
Issuer symbol
AGEN
Transactions as of
01 Oct 2025
Transactions value $
$0
Form type
4
Filing time
03 Oct 2025, 16:05:04 UTC
Previous filing
03 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wright Timothy Director C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON /s/Christine Klaskin as Attorney-in-Fact for Timothy R. Wright 03 Oct 2025 0001383313

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Deferred Stock Units Award +1.7K +8.45% 21.9K 01 Oct 2025 Common Stock 1.7K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.
F2 Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.
F3 $5.01 per Deferred Stock Unit acquired on July 1, 2025. The price of each Deferred Stock Unit acquired on October 1, 2025 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.